Clinical & Molecular Biomedicine
About Journal
Clinical & Molecular Biomedicine
Journal Overview
Clinical & Molecular Biomedicine (CMB) is an international, peer-reviewed, open-access journal that publishes high-quality research connecting molecular discoveries with clinical applications.
The journal aims to promote interdisciplinary research bridging basic molecular science and clinical medicine, enabling the translation of laboratory discoveries into improved patient care.
CMB is committed to rigorous, fair, and timely peer review, strong publication ethics, reproducibility, and clinically meaningful translational outcomes.
Its scope spans translational medicine, molecular and cellular biology, clinical biochemistry, genomics and epigenetics, proteomics and metabolomics, microbiome research, molecular oncology, neurobiology, biomarker discovery, drug discovery and resistance, gene and cell therapy, precision medicine, and immunology and vaccinology.
1. About the Journal
Clinical & Molecular Biomedicine (CMB) is an international, peer-reviewed, open-access journal that publishes high-quality research connecting molecular discoveries with clinical applications.
The journal provides a platform for scientists, clinicians, and biomedical researchers to disseminate advances in translational medicine that improve understanding, diagnosis, and treatment of human diseases.
The journal aims to promote interdisciplinary research bridging basic molecular science and clinical medicine, enabling the translation of laboratory discoveries into improved patient care.
The journal focuses on translational biomedical research integrating molecular biology, clinical medicine, and emerging biomedical technologies in the following research areas:
- Translational medicine
- Molecular and cellular biology
- Clinical biochemistry
- Genomics and epigenetics
- Proteomics and metabolomics
- Microbiome research
- Molecular oncology
- Neurobiology
- Biomarker discovery
- Drug discovery and resistance
- Gene and cell therapy
- Precision medicine
- Immunology and vaccinology
2. Mission of the Journal
The mission of CMB is to promote research that moves discoveries from bench to bedside, accelerating the development of diagnostics, therapeutics, and personalized medicine.
The journal is committed to rigorous, fair, and timely peer review by experts in the field.
Clinical & Molecular Biomedicine adheres to the highest standards of research ethics, data reporting, and reproducibility, ensuring that all published work is both scientifically sound and clinically meaningful.
3. Key Features
- Rigorous peer-review process
- Open access publishing
- No article processing charge (APC)
- Rapid editorial decision
- Global editorial board
- International authorship
4. Scope of the Journal
Clinical & Molecular Biomedicine (CMB) publishes innovative research that advances understanding of disease mechanisms and clinical interventions.
The primary aim of CMB is to publish studies that explain the molecular mechanisms underlying human diseases and translate these findings into clinically meaningful outcomes.
The journal welcomes interdisciplinary studies combining experimental, computational, and clinical research approaches.
Major research themes
- Genomics and Epigenetics
- Proteomics and Metabolomics
- Translational Oncology
- Molecular Neurobiology
- Biomarker Discovery
- Drug Target Discovery
- Precision Medicine
Genomics and Epigenetics
Identification of disease-associated genetic variants and epigenetic modifications.
Proteomics and Metabolomics
Discovery of molecular biomarkers and metabolic pathways associated with disease.
Translational Oncology
Research focusing on cancer biomarkers, molecular diagnostics, and targeted therapies.
Molecular Neurobiology
Studies investigating molecular mechanisms of neurological disorders.
Biomarker Discovery
Identification and validation of diagnostic, prognostic, and therapeutic biomarkers.
Drug Target Discovery
Research identifying novel molecular targets for therapeutic intervention.
Precision Medicine
Integration of molecular data for personalized therapeutic strategies.
5. Article Types
The journal accepts several categories of manuscripts.
- Original Research Articles: Full-length reports describing novel experimental or clinical findings.
- Review Articles: Comprehensive and critical reviews summarizing current knowledge in a specific field.
- Short Communications: Brief reports presenting important preliminary findings.
- Case Reports: Clinical observations offering novel insights into disease or treatment.
- Methods and Protocols: Descriptions of new techniques or improved experimental methodologies.
- Letters to the Editor: Comments or discussions related to previously published articles.
6. Peer Review and Editorial Decision
This journal follows a single anonymized review process.
Your submission will initially be assessed by our editors to determine suitability for publication in this journal.
If your submission is deemed suitable, it will typically be sent to a minimum of two reviewers for an independent expert assessment of the scientific quality.
The decision as to whether your article is accepted or rejected will be taken by our editors.
The Editor-in-Chief has final authority over all editorial decisions.
Editorial Decision
Possible decisions include:
- Accept
- Minor revision
- Major revision
- Reject
7. Ethics and Policies
CMB follows internationally recognized publication ethics guidelines from organizations such as:
- Committee on Publication Ethics (COPE)
- International Committee of Medical Journal Editors (ICMJE)
- World Association of Medical Editors (WAME)
Ethical requirements include
- Original research only
- No plagiarism or duplicate publication
- Accurate reporting of data
- Proper citation of sources
- Ethical approval for human and animal research
Submission declaration
When authors submit an article to a journal of EditoryPress, it is implied that:
- The work described has not been published previously except in the form of a preprint, an abstract, a published lecture, an academic thesis, or a registered report.
- The article is not under consideration for publication elsewhere.
- The article's publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out.
- If accepted, the article will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright-holder.
9. Statements and Declarations
The following statements must be included in your submitted manuscript under the heading 'Statements and Declarations'. This should be placed after the References section.
Declaration of competing interests / Conflict of Interest
All authors must disclose any financial or personal relationships with individuals or organizations that could inappropriately influence, or be perceived to influence, their work.
A conflict of interest (COI) exists when professional judgment concerning a primary interest may be influenced by a secondary interest.
- Research funding or grants
- Employment or consultancy
- Honoraria or speaking fees
- Patents or patent applications
- Stock ownership or other financial investments
- Advisory or leadership roles in organizations
- Institutional or professional affiliations
- Personal relationships
- Academic competition
- Strong intellectual, ideological, or political positions that may affect interpretation of results
Funding sources
Authors must clearly disclose all sources of financial support received for the conduct of the research and/or the preparation of the manuscript.
Authors should state the role of the funding organization or sponsor, if any, in the following aspects of the study:
- Study design
- Data collection
- Data analysis and interpretation
- Manuscript preparation
- Decision to submit the manuscript for publication
Use of Inclusive Language
The journal encourages the use of inclusive and respectful language in all submitted manuscripts.
Authors should ensure that their writing avoids expressions that could imply that one individual or group is superior to another based on characteristics such as:
- Age
- Gender
- Race
- Ethnicity
- Culture
- Sexual orientation
- Disability or health condition
Reporting Sex- and Gender-Based Analyses
Research involving humans, animals, or eukaryotic cells should consider sex- and gender-based analyses (SGBA) when relevant.
Authors are encouraged to:
- Consider sex and/or gender variables during study design and data analysis when appropriate.
- Clearly describe how sex and/or gender were considered in the research methodology.
- Address the influence of sex or gender in the interpretation of results, when relevant.
- Acknowledge any limitations in the generalizability of the findings if sex- or gender-based analyses were not conducted.
10. Manuscript Submission
Authors submitting manuscripts to CMB must ensure that their work is original, unpublished, and not under consideration, in part or in full, either in print or electronic format, by another journal.
Submission Checklist
Before finalizing the submission of your manuscript, authors are strongly advised to carefully review the following checklist to ensure completeness and compliance with journal requirements:
- One author has been clearly designated as the corresponding author, and complete contact details, including email address, full postal address, and telephone number have been provided.
- All required files have been uploaded successfully. This includes the main manuscript, keywords, figure captions, tables, supplementary materials, and any video or multimedia files, where applicable.
- The manuscript has undergone thorough spelling and grammar checks to ensure clarity and accuracy of language.
- All references cited within the text are included in the reference list, and all references listed are appropriately cited in the text.
- Necessary permissions have been obtained for any copyrighted material reproduced from other sources, including online content.
Online Submission
Please follow the hyperlink “Submit manuscript” and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files at every submission and revision. For your manuscript text, please always submit in common word processing formats such as .docx or LaTeX.
Please note that Author Contribution information and Competing Interest information must be provided at submission via the submission interface.
Cover Letter
A cover letter must accompany every submission and should:
- Describe the scope, importance, and novelty of the manuscript.
- Disclose any potential competing interests.
- Confirm originality and exclusivity of submission to CMB.
- Acknowledge author contributions and funding sources.
- Suggest potential reviewers and optionally request exclusion of up to 5 reviewers.
- Provide complete contact details for all authors, identifying the corresponding author clearly.
11. Submission File Format
For submissions to Clinical & Molecular Biomedicine (CMB), authors are required to provide editable source files for all components of the manuscript, including the main text, figures, tables, and graphical elements.
Providing editable files facilitates efficient handling during the peer-review, copyediting, and production processes.
- File Format: Manuscripts must be submitted in an editable format. Use .doc or .docx for Microsoft Word files and .tex for LaTeX submissions. PDF files are not accepted as source files for manuscript submissions.
- Document Layout: Manuscripts prepared in Microsoft Word should use a single-column layout. Double-column formatting is permitted only for manuscripts prepared using LaTeX.
- Clean Formatting: Before submission, authors should remove tracked changes, strikethrough text, and unnecessary underlining from the manuscript, unless such formatting is scientifically relevant to the content of the article.
- Language and Formatting Check: Authors are encouraged to use spell-check and grammar-check tools to ensure clarity, accuracy, and consistency in language throughout the manuscript.
12. Manuscript Preparation
Formatting guidelines: Manuscripts should be submitted in Word.
- Use a normal, plain font (e.g., 12-point Times Roman) for text with 1.5 line spacing.
- Use italics for emphasis.
- Use the automatic page numbering function to number the pages.
- Do not use field functions.
- Use tab stops or other commands for indents, not the space bar.
- Use the table function, not spreadsheets, to make tables.
- Use the equation editor or MathType for equations.
- Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).
- Tables in editable Word format (separate or embedded in the text file)
- Figures as high-resolution editable artwork (separate or embedded in the text file)
Manuscript Structure
Manuscripts should be organized in the following sections:
- Title page
- Abstract
- Keywords
- Introduction
- Materials and Methods
- Results
- Discussion
- Conclusions
- Funding
- Acknowledgments
- References
- Figure legends
- Tables and figures
Title Page
The title page should include the following information:
- Article Title
- Author Names
- Author Affiliations
- Corresponding Author
- Present or Permanent Address
Abstract
Abstracts must be able to stand alone, as abstracts are often presented separately from the article. The abstract should be 150–250 words and include:
- Background
- Methods
- Key results
- Conclusions
Keywords
Provide 4–6 keywords for indexing purposes.
13. Tables, Figures, Images, and Artwork
Tables
Tables should be prepared in an editable text format and must not be submitted as images.
- Tables must be numbered consecutively using Arabic numerals according to the order in which they are first mentioned in the text.
- Each table should be cited in the manuscript text in sequential numerical order.
- Tables should be placed as close as possible to the relevant text within the manuscript or on separate pages at the end of the document.
- Every table must include a clear, descriptive, and concise caption positioned above the table.
- Footnotes should be used where necessary and placed directly below the table body.
- Authors should avoid vertical lines, excessive formatting, or cell shading.
Figures, Images, and Artwork
High-quality figures are essential for effectively conveying the complexity and significance of translational research.
All figures should be submitted as separate high-resolution files, in addition to being appropriately placed within the manuscript.
Electronic Figure Submission
- Figure files should be named consecutively using the format Fig followed by the figure number (e.g., Fig1.tiff, Fig2.eps).
- Vector graphics: Preferred formats are EPS or PDF, with all fonts embedded.
- Halftone images/photographs: Preferred format is TIFF.
- Other acceptable formats: JPG and PNG (meeting resolution requirements).
- MS Office files (.docx, .pptx) are acceptable only if figures are properly embedded and maintain adequate resolution.
Resolution Requirements (Minimum DPI)
- Photographs/halftone images: 300 dpi
- Combination figures (images with text/line elements): 500–600 dpi
- Line art (black and white, no shading): 1000–1200 dpi
Color Figures
- Color figures are published free of charge in the online version.
- Submit color images in RGB format (8 bits per channel).
- Authors must ensure that figures remain clear and interpretable when converted to grayscale for print.
Figure Lettering and Style
- Use standard sans-serif fonts such as Arial or Helvetica.
- Maintain consistent font type and size across all figures.
- Recommended font size: 8–12 pt.
- All text must remain legible after resizing for publication.
- Lines must be clear and sharp, with a minimum thickness of 0.1 mm (0.3 pt).
- Avoid decorative elements such as shadows, gradients, or outlined text.
- For images involving magnification, scale bars must be included within the figure.
Figure Numbering and Captions
- Figures must be numbered consecutively using Arabic numerals according to their order of appearance.
- All figures must be cited in the manuscript text in sequential order.
- Multi-panel figures should be labeled using lowercase letters (a, b, c).
- Captions must be provided in the main manuscript file, not within the figure image.
- Each caption should begin with “Fig.” followed by the figure number.
- Captions should include a concise descriptive title, a clear explanation of figure content, and identification of all symbols and abbreviations.
Figure Placement and Size
- Figures should be placed close to their first citation in the manuscript or grouped at the end.
- Single-column width: approximately 84 mm.
- Double-column width: approximately 174 mm.
- All elements within the figure must remain clear and legible at the intended publication size.
Generative AI and Ethical Considerations
The use of generative artificial intelligence (AI) or AI-assisted tools to create or modify figures is generally not permitted.
An exception may be made when AI tools are used as part of the research methodology. In such cases, authors must provide full transparency in the Methods section.
AI-generated artwork requires prior editorial approval, along with appropriate disclosure and attribution.
14. Supplementary Material and Multimedia
Authors are encouraged to submit supplementary material to support and enhance the scientific content of their manuscripts.
Supplementary material may include extended datasets, additional figures and tables, high-resolution images, multimedia files (audio/video), software, protocols, or other supporting information that is directly relevant to the study.
Guidelines for Supplementary Material
- Supplementary files must be accurate, relevant, and directly related to the research presented in the manuscript.
- All supplementary materials must be clearly cited and appropriately referenced within the manuscript text.
- Authors must submit all supplementary files simultaneously with the initial manuscript submission.
- Each supplementary file should include a clear, concise, and descriptive caption.
- Supplementary materials may be added, updated, or replaced only during the revision stage.
Video and Multimedia Content
Clinical & Molecular Biomedicine (CMB) welcomes the submission of video files and animation sequences that enhance the presentation of scientific content.
- All video and multimedia content must be clearly referenced within the manuscript text.
- Each file should be assigned a descriptive and logically structured filename.
- Videos should be submitted in commonly accepted file formats and must not exceed 150 MB per file or a total of 1 GB for all submitted multimedia files.
- Authors must provide a representative still image (snapshot) for each video file.
- A concise and descriptive explanation of each video’s content should be included in the manuscript.
15. Research Data, Footnotes, Acknowledgements, and CRediT
Research Data
The journal supports open, transparent, and reproducible research practices and strongly encourages authors to share their research data wherever possible.
- Deposit research data in a recognized public repository, where appropriate.
- Cite and link datasets within the manuscript to facilitate access and verification.
- Provide sufficient methodological and contextual information to enable other researchers to interpret, validate, and reuse the data.
Data Availability Statement
Authors are encouraged to include a Data Availability Statement in their manuscript. This statement should clearly indicate:
- Where and how the data can be accessed (e.g., repository name, accession number, or persistent link), or
- The reasons for restricted access, where applicable.
Footnotes
Footnotes should be used sparingly and only when necessary to provide additional clarification that cannot be integrated into the main text without disrupting its flow.
- Footnotes must be numbered consecutively throughout the manuscript.
- Authors are encouraged to use the automatic footnote feature available in word-processing software.
- Alternatively, footnotes may be indicated within the text and compiled in a separate section at the end of the manuscript.
Acknowledgements
Authors may acknowledge individuals, institutions, or organizations that provided support or assistance during the course of the research or the preparation of the manuscript.
Acknowledgements must be presented in a separate section titled “Acknowledgements”, placed immediately before the reference list.
- Only individuals or entities who made meaningful but non-authorship contributions are acknowledged.
- All acknowledged individuals have given permission to be named, where applicable.
16. References and Permissions
References in the Text
All references cited in the manuscript must be included in the reference list, and all entries in the reference list must be cited in the text.
- References cited in the abstract must also be provided in full in the reference list.
- Unpublished results and personal communications should generally not be included in the reference list.
- References cited as “in press” indicate that the work has been accepted for publication but is not yet available in final form.
- Authors must ensure that all reference details are accurate and complete at the time of submission.
Reference Style
Clinical & Molecular Biomedicine (CMB) follows a numbered citation style:
- References should be indicated by numbers in square brackets within the text.
- References must be numbered consecutively in the order in which they first appear in the manuscript.
- Where appropriate, author names may be mentioned in the text, but the corresponding reference number must always be included.
Permissions
Authors who wish to include figures, tables, or text excerpts that have been previously published must obtain written permission from the original copyright holder(s) prior to submission.
The granted permission must explicitly allow use of the material in both print and online formats of Clinical & Molecular Biomedicine (CMB).
- Obtain all necessary permissions before submitting the manuscript.
- Ensure that permissions cover the intended scope of reuse.
- Provide documented evidence of permission at the time of submission.
17. Research Ethics and Informed Consent
All research involving human participants, human data, animals, or animal-derived materials must adhere to the highest ethical standards.
Authors are required to include the following mandatory statements under the “Statements and Declarations” section of the manuscript.
A. Ethics Approval Statement (Human and Animal Studies)
Authors must confirm that the study was conducted in accordance with established ethical guidelines and was approved by the appropriate institutional or national authority.
- A formal statement must indicate that the study received approval (or exemption) from a recognized body such as an Institutional Review Board (IRB), Ethics Committee, or Institutional Animal Care and Use Committee (IACUC).
- The statement must include the full name of the approving body, along with the approval/reference number and date, where applicable.
B. Informed Consent to Participate (Human Subjects)
For all studies involving human participants, authors must confirm that freely given, informed consent was obtained.
- A statement confirming that consent was obtained from all participants must be included in the manuscript.
- For minors or vulnerable populations, consent must be obtained from parents or legal guardians.
C. Consent to Publish (Individual Data)
If the manuscript includes any identifiable individual data, authors must obtain explicit consent for publication from the individual concerned.
- A statement confirming that consent to publish has been obtained must be included in the manuscript.
18. Language Editing, Acceptance, and Open Access
Language Editing
Authors are encouraged to ensure that their manuscript is written in clear, concise, and grammatically correct English.
- English language editing
- Developmental and structural feedback
- Manuscript formatting
- Figure preparation
- Translation services
Upon Acceptance / Publishing Agreement
Upon acceptance of the manuscript, authors will be required to complete a publishing agreement.
The corresponding author will receive an email containing a secure link to the online agreement form.
Copyright and Licensing
Authors retain full copyright ownership of their work.
By choosing open access publication, authors agree to publish their article under a Creative Commons Attribution (CC BY) license, which permits:
- Redistribution
- Reuse and adaptation
- Commercial use provided that appropriate credit is given to the original authors and source
Proofreading
The primary purpose of the proof stage is to identify and correct typesetting, formatting, or conversion errors, and to ensure the overall accuracy and completeness of the manuscript.
- The corresponding author will receive access to an online proofing system.
- This system functions similarly to a word processor, enabling authors to edit text, comment on figures and tables, and respond to queries raised by the copy editor.
- Substantial changes to content are not permitted at this stage without prior approval from the Editor.
Online First Publication
Accepted articles are published online shortly after the corrected proofs are received.
This Online First version represents the official first publication and is fully citable using its DOI.
Open Access
All articles published in Clinical & Molecular Biomedicine (CMB) are made available through a fully open-access model, ensuring immediate and unrestricted access to readers worldwide.
Article Processing Charges (APCs) – FREE
Currently, no article processing charges are required for publication.
- Increased accessibility
- Greater visibility and impact
- Compliance with funding requirements
- Immediate and unrestricted access to all articles
- Publication under the CC BY license
- Promotion of equitable access to scientific knowledge regardless of institutional or financial constraints
19. Corrections, Retractions, and Publication Ethics
To maintain the integrity and reliability of the scholarly record, the journal may issue formal notices in cases where errors or concerns arise after publication.
Authors are expected to uphold the highest standards of integrity, transparency, and accountability in the conduct and reporting of their research.
Any violation of these principles constitutes research misconduct and will be addressed in accordance with internationally recognized ethical guidelines, including those of the Committee on Publication Ethics (COPE).
The journal maintains a strict policy against all forms of academic and research misconduct.
- Erratum – to correct errors introduced during publication
- Corrigendum – to correct errors made by the authors
- Expression of Concern – issued when there are unresolved concerns about the integrity of the work
- Retraction – issued in cases of significant errors or ethical issues that invalidate the findings
Possible Outcomes of Misconduct Investigations
Depending on the findings, the journal may take one or more of the following actions:
- Rejection of the manuscript
- Publication of a formal correction
- Retraction of the published article
- Notification of the authors’ affiliated institutions or funding bodies
Highlights
- International, peer-reviewed, open-access journal connecting molecular discoveries with clinical applications.
- Promotes translational medicine that improves understanding, diagnosis, and treatment of human diseases.
- Covers genomics, proteomics, microbiome research, molecular oncology, neurobiology, biomarker discovery, drug target discovery, and precision medicine.
- Single anonymized peer review with editor screening and typically at least two reviewers.
- Article processing charge (APC) is FREE.
Abstract
Clinical & Molecular Biomedicine (CMB) is an international, peer-reviewed, open-access journal that publishes high-quality research connecting molecular discoveries with clinical applications.
The journal provides a platform for scientists, clinicians, and biomedical researchers to disseminate advances in translational medicine that improve understanding, diagnosis, and treatment of human diseases.
Keywords
- Translational medicine
- Molecular biology
- Clinical biochemistry
- Genomics and epigenetics
- Biomarker discovery
- Precision medicine